Profile data is unavailable for this security.
About the company
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
- Revenue in JPY (TTM)27.68bn
- Net income in JPY1.33bn
- Incorporated1980
- Employees878.00
- LocationAFC-HD AMS Life Science Co Ltd3-6-36, Toyoda, Suruga-kuSHIZUOKA-SHI 422-8027JapanJPN
- Phone+81 542810585
- Fax+81 542815979
- Websitehttp://www.ams-life.com/
More ▼
Mergers & acquisitions
| Acquired company | 2927:TYO since announced | Transaction value |
|---|---|---|
| Kurearaizu | 6.98% | -- |
Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oomitsu Co Ltd | 69.49bn | 519.07m | 9.56bn | 553.00 | 18.17 | 1.67 | 9.49 | 0.1376 | 35.56 | 35.56 | 4,754.99 | 387.08 | 3.42 | 12.19 | 13.60 | 125,659,700.00 | 2.55 | 0.7128 | 5.20 | 1.61 | 19.06 | 19.33 | 0.747 | 0.2127 | 0.6769 | 296.46 | 0.5638 | 96.25 | 16.40 | 1.37 | 2,353.75 | -6.04 | 10.51 | 7.39 |
| NittoBest Corporation | 53.97bn | 373.39m | 9.83bn | 1.87k | 26.47 | 0.6357 | 4.48 | 0.1822 | 30.86 | 30.86 | 4,461.44 | 1,285.15 | 1.23 | 6.63 | 4.46 | 28,847,960.00 | 0.9047 | 1.30 | 1.75 | 2.26 | 17.02 | 19.21 | 0.7347 | 0.9839 | 0.865 | 10.41 | 0.3875 | 27.98 | 4.29 | -0.1438 | -59.99 | -24.70 | 6.38 | 0.00 |
| Morishita Jintan Co Ltd | 12.36bn | 785.00m | 10.02bn | 328.00 | 12.63 | 0.8243 | 7.26 | 0.8104 | 192.22 | 192.22 | 3,026.69 | 2,944.33 | 0.7594 | 2.42 | 5.16 | 37,685,980.00 | 4.82 | 2.28 | 5.84 | 2.71 | 48.62 | 50.84 | 6.35 | 3.30 | 1.31 | -- | 0.0483 | 46.64 | 18.78 | 1.01 | 73.50 | 4.50 | 8.12 | 1.30 |
| Como Co Ltd | 7.14bn | -46.97m | 10.54bn | 210.00 | -- | 5.21 | 35.81 | 1.47 | -13.52 | -13.52 | 2,056.65 | 557.31 | 1.34 | 28.56 | 6.11 | 34,022,860.00 | -0.8828 | 3.74 | -1.78 | 6.86 | 24.90 | 32.78 | -0.6574 | 2.71 | 0.6656 | -9.45 | 0.4935 | 15.14 | 8.14 | 4.49 | -78.31 | -25.17 | -1.80 | 0.00 |
| Wakou Shokuhin Co., Ltd. | 14.76bn | 903.74m | 11.12bn | 264.00 | 10.75 | 1.43 | 8.25 | 0.7532 | 363.39 | 363.39 | 5,938.77 | 2,722.38 | 1.25 | 5.87 | 5.69 | 55,926,840.00 | 7.64 | 3.14 | 11.98 | 4.95 | 27.44 | 24.30 | 6.12 | 2.39 | 1.14 | -- | 0.3496 | 14.97 | 17.50 | 8.48 | 171.24 | -- | -8.14 | 5.39 |
| Dairei Co Ltd | 27.87bn | 750.32m | 11.45bn | 151.00 | 15.01 | 1.18 | 14.51 | 0.4109 | 126.96 | 126.96 | 4,716.01 | 1,620.19 | 2.02 | 7.12 | 4.66 | 184,569,800.00 | 5.45 | 6.91 | 7.68 | 9.35 | 15.94 | 16.78 | 2.69 | 3.14 | 2.35 | -- | 0.078 | 43.18 | 18.62 | -0.1484 | 40.37 | 12.04 | 67.22 | 1.76 |
| Toyo Sugar Refining Co Ltd | 16.93bn | 1.40bn | 11.81bn | 72.00 | 8.45 | 1.09 | 8.04 | 0.6977 | 256.20 | 256.20 | 3,104.90 | 1,989.86 | 1.33 | 6.93 | 8.83 | 235,138,900.00 | 11.01 | 4.79 | 12.96 | 5.67 | 14.75 | 18.87 | 8.26 | 4.01 | 3.52 | -- | 0.00 | 36.64 | 12.89 | 1.68 | -10.70 | -8.09 | -8.97 | 3.13 |
| AFC-HD AMS Life Science Co Ltd | 27.68bn | 1.33bn | 12.13bn | 878.00 | 8.89 | 0.8701 | 5.13 | 0.4382 | 94.78 | 94.78 | 1,971.88 | 968.81 | 0.6648 | 3.45 | 9.65 | 31,522,990.00 | 3.20 | 3.44 | 5.10 | 5.33 | 35.79 | 32.85 | 4.81 | 4.66 | 0.8848 | 1,246.98 | 0.6148 | 38.08 | 11.09 | 10.12 | 49.94 | 8.40 | 28.70 | 6.58 |
| Shinobu Foods Products Co Ltd | 54.00bn | 485.00m | 12.16bn | 528.00 | 23.92 | 0.7594 | 6.03 | 0.2251 | 39.08 | 39.08 | 4,356.88 | 1,231.31 | 1.70 | 120.81 | 9.09 | 102,272,700.00 | 1.54 | 2.64 | 2.23 | 3.80 | 14.65 | 16.29 | 0.9037 | 1.55 | 1.32 | 1,218.50 | 0.3421 | 29.49 | 4.92 | 1.54 | -90.47 | -31.68 | -12.25 | 6.96 |
| PIETRO Co., Ltd. | 9.79bn | -170.73m | 12.64bn | 293.00 | -- | 1.94 | 48.31 | 1.29 | -28.37 | -28.37 | 1,599.31 | 921.35 | 0.9737 | 12.85 | 5.95 | 33,402,730.00 | -1.70 | 1.32 | -2.60 | 1.93 | 52.22 | 56.91 | -1.74 | 1.27 | 1.21 | 17.42 | 0.2222 | 115.25 | 6.65 | -1.08 | -341.78 | -- | 21.79 | 3.71 |
| Unicafe Inc | 12.36bn | 442.89m | 12.72bn | 213.00 | 27.69 | 1.99 | 14.74 | 1.03 | 33.12 | 33.12 | 924.16 | 460.72 | 0.888 | 11.94 | 3.91 | 58,018,300.00 | 3.18 | -2.53 | 5.24 | -3.78 | 21.65 | 19.15 | 3.58 | -2.52 | 1.31 | -- | 0.2932 | -- | 15.34 | 3.41 | 332.19 | -1.30 | 18.28 | 0.00 |
| Miyoshi Oil & Fat Co Ltd | 56.24bn | 2.08bn | 12.82bn | 567.00 | 6.12 | 0.4508 | 3.38 | 0.228 | 203.19 | 203.19 | 5,503.08 | 2,759.40 | 0.9287 | 5.57 | 3.16 | 99,181,660.00 | 3.44 | 1.79 | 5.93 | 2.87 | 17.12 | 15.16 | 3.71 | 1.98 | 0.9376 | -- | 0.2925 | 42.72 | 6.62 | 4.25 | 875.00 | 24.73 | 8.10 | 4.56 |
| Nitta Gelatin Inc | 39.96bn | -946.00m | 13.10bn | 1.02k | -- | 0.7238 | 7.94 | 0.3279 | -52.02 | -52.02 | 2,202.33 | 985.13 | 0.9763 | 2.37 | 4.56 | 39,059,630.00 | -0.3274 | 2.47 | -0.5261 | 3.88 | 20.49 | 21.37 | -0.3354 | 2.62 | 1.06 | -- | 0.3209 | 38.24 | 23.29 | 0.7351 | 114.60 | -- | 9.33 | 5.92 |
| Ichimasa Kamaboko Co Ltd | 33.59bn | 434.38m | 13.98bn | 935.00 | 31.81 | 0.9785 | 6.62 | 0.4162 | 23.64 | 23.64 | 1,827.69 | 768.54 | 1.07 | 6.35 | 4.87 | 35,922,410.00 | 1.38 | 3.53 | 2.27 | 5.26 | 17.83 | 23.63 | 1.29 | 2.49 | 0.8488 | -- | 0.4733 | 21.31 | 3.72 | -1.30 | -85.12 | -31.50 | 38.61 | 11.38 |
| DAISHO CO., LTD. | 24.89bn | 527.00m | 13.98bn | 707.00 | 25.95 | 1.39 | 11.79 | 0.5619 | 54.60 | 54.60 | 2,578.14 | 1,018.57 | 1.43 | 9.59 | 4.02 | 35,199,440.00 | 3.05 | 2.91 | 4.60 | 4.13 | 38.18 | 40.59 | 2.13 | 1.95 | 1.29 | 64.17 | 0.0484 | 40.30 | 3.09 | 2.70 | -44.74 | -4.77 | 33.30 | 0.00 |
| CHUO GYORUI Co., Ltd. | 136.55bn | 1.80bn | 14.09bn | 760.00 | 7.24 | 0.4765 | 3.38 | 0.1032 | 450.85 | 450.85 | 34,178.48 | 6,852.46 | 1.58 | 12.63 | 5.76 | 179,665,800.00 | 2.24 | 1.90 | 3.93 | 2.95 | 9.51 | 7.12 | 1.41 | 0.7935 | 0.9214 | -- | 0.4834 | 25.94 | 12.84 | -7.21 | 20.40 | 33.51 | 10.28 | 3.13 |
Data as of May 02 2024. Currency figures normalised to AFC-HD AMS Life Science Co Ltd's reporting currency: Japanese Yen JPY
0.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 86.80k | 0.60% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 23.10k | 0.16% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 13.08k | 0.09% |
| Daiwa Asset Management Co. Ltd.as of 15 Apr 2022 | 3.70k | 0.03% |
| DFA Australia Ltd.as of 31 May 2023 | 1.80k | 0.01% |
More ▼
Data from 31 Dec 2023 - 25 Apr 2024Source: FactSet Research Systems Inc.
